Table 1. Demographic and clinical data of the study population (n = 315).
| Baseline | Follow-up 12 months | P value | |
|---|---|---|---|
| Mean age and std. dev. (yr) | 52 (16) | ||
| Male gender (no. [%]) | 167 (53) | ||
| Dominant shoulder (no. [%]) | 198 (63) | ||
| Duration of symptoms (months; SD) | 32 (40) | ||
| History of surgery (no. [%]) | 32 (10) | ||
| Distress | |||
| symptoms (mean (SD)) | 5.9 (5.8) | 5.2 (7.0)* | 0,06 |
| medium/high risk (no. [%]) | 20 (20%) | 18%* | |
| Depression | |||
| symptoms (mean (SD)) | 0.5 (1.6) | 0.89 (2.1)* | 0,01 |
| medium/high risk (no. [%]) | 24 (7%) | 15%* | |
| Anxiety | |||
| symptoms ((mean (SD)) | 1.1 (2.0) | 1.2 (2.9)* | 0,44 |
| medium/high risk (no. [%]) | 43 (13%) | 13%* | |
| Somatisation | |||
| symptoms ((mean (SD)) | 6.4 (5.0) | 6.4 (6.2)* | 0,82 |
| medium/high risk (no. [%]) | 46 (15%) | 18%* | |
| Mean (SD) VAS pain in rest | 1.7 (2.2) | 1.6 (2.2) | 0,08 |
| Mean (SD) VAS pain during activity | 7.9 (5.1) | 2.5 (2.6) | <0.001 |
| Mean DASH score and std. dev. | 40.5 (20.9) | 16.8 (17.0) | <0.001 |
| Anchor question pain | |||
| mean and std. dev. | 6.1 (0.9) | ||
| ≥ 5 | 92% | ||
| Anchor question function | |||
| mean and std. dev. | 6.0 (1.1) | ||
| ≥ 5 | 91% |
* n = 176